Glutamate and Schizophrenia

Professor Daniel Weinberger discusses evidence from a number of research areas that highlight the importance of the neurotransmitter glutamate in schizophrenia.

So how does glutamate relate to schizophrenia? For probably forty years, most of the work on schizophrenia was focused on dopamine. But because the evidence has increasingly centered around areas of the brain like the frontal lobe and the hippocampus, which are the so-called cortical regions of the brain, there’s been a lot more interest in what are the neurotransmitters that are critical for how the cortex works. And in the cortex, the main neurotransmitters are amino acid neurotransmitters like glutamate and GABA. Glutamate is the principle neurotransmitter of cells that communicate across long distances in the brain. Such as across cortical regions and from the cortex down into the spinal cord or out into the rest of your body. And glutamate is a critical molecule for the function of the cortex. Based on those observations, there’s been a lot of research to look at glutamate. And there’s a pharmacological model of schizophrenia based on the blocking of certain glutamate receptors, a particular glutamate receptor called the NMDA receptor, which is the N-methyl-D-aspartate receptor. There’s a drug, a street drug, called PCP which blocks this receptor. Associated with the use of this drug is a psychotic-like state – not just a psychotic state but also change in cognitive function, change in the ability to pay attention, distraction which have certain features of schizophrenia. So there’s been a pharmacological model of schizophrenia based on glutamate. Turns out, so far, most of the genes that have been found that relate to schizophrenia, particularly neuregulin, dysbindin, COMT – some other genes like GRM3, AKT1, calcineurin, etc. – many of these genes seem to impact on the function of glutamate in the brain. So glutamate might be a final common pathway that many of the biological risk factors impact upon to translate into the kind of behavior and brain function we see in schizophrenia.

schizophrenia, glutamate, receptor, neurotransmitter, neurotransmission, nmda, hippocampus, pcp, daniel, weinberger

Related Content

1182. Glutamate Hypothesis of Schizophrenia

Professor Jeffrey Lieberman discusses the glutamate hypothesis of schizophrenia. The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms.

  • ID: 1182
  • Source: G2C

2226. Schizophrenia

An overview of schizophrenia-related content on Genes to Cognition Online.

  • ID: 2226
  • Source: G2C

510. GRM3 Gene

Metabotropic Glutamate Receptor-3 (GRM3) is a candidate gene for schizophrenia.

  • ID: 510
  • Source: G2C

1211. What is NMDA?

Professor Seth Grant explains that NMDA is an amino acid derivative very similar to glutamate - the brain's primary excitatory neurotransmitter.

  • ID: 1211
  • Source: G2C

811. The Glutamate System

Professor Trevor Robbins describes some of the key functions of the excitatory glutamate system, which is integral to information processing and long-term potentiation.

  • ID: 811
  • Source: G2C

1169. COMT expression

Professor Daniel Weinberger explains that the schizophrenia candidate gene, COMT, is abundantly expressed in the hippocampus and prefrontal cortex.

  • ID: 1169
  • Source: G2C

1165. Dopamine and Schizophrenia

Professor Daniel Weinberger explains that dopamine is the major focus of biochemical research into schizophrenia.

  • ID: 1165
  • Source: G2C

923. DAOA/G72

Polymorphisms of DAOA are associated with schizophrenia and bipolar disorder risk.

  • ID: 923
  • Source: G2C

868. Candidate Genes for Schizophrenia

An interactive chromosome map of the genes and loci associated with schizophrenia.

  • ID: 868
  • Source: G2C

1164. Hippocampus and Schizophrenia

Professor Daniel Weinberger discusses evidence that abnormalities in the hippocampus are associated with schizophrenia.

  • ID: 1164
  • Source: G2C